NNovo Nordisk Read More Novo CEO faces investor grilling after obesity drug disappointments2026-08-05 Ozempic manufacturer Novo Nordisk faces challenges as the patent on semaglutide expire in one country after the other.…
NNovo Nordisk Read More Novo Nordisk announces new, cheaper Ozempic copy for SA2026-07-17 Danish drugmaker Novo Nordisk says it is ready to release a cheaper copy of its Ozempic diabetes medication,…
BBrussels Read More From Brussels’ downstream to the shadow of corruption: what do we know about the covid-19 rescue fund?2026-07-05 MadridThe covid-19 pandemic blew up part of the economic postulates that had prevailed in Europe since the financial…
NNovo Nordisk Read More Copycat or compound? SA’s GLP-1 turf war heads to court, and it may gut some pharmacies2026-06-08 The explosive growth of demand for GLP-1 drugs has prompted an interesting court battle that could set precedents…
BBerlin Read More Bulletin from Berlin: When you feel like there’s no stability in the presence, it’s hard to plan for the future2026-04-17 Opinion by Cathrin Schaer Europe correspondent·New Zealand Listener· 16 Apr, 2026 06:00 PM3 mins to read Cathin Schaer…